BCR-ABL-IN-7

Customer Review

Based on 1 Customer Validation

BCR-ABL-IN-7 (compound 4) is a WT and T315I mutant ABL kinases inhibitor. BCR-ABL-IN-7 effectively inhibits activities of WT and T315I mutant ABL kinases. BCR-ABL-IN-7 can be used for the research of chronic myeloid leukemia (CML) research.

For research use only. We do not sell to patients.

  • Purity: 99.66%
  • CAS No.: 688050-42-2
  • Formula: C19H16FN3O3S
  • Molecular Weight:385.41
  • Storage:

    4°C, protect from light

    * In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)

  • Biological Activity
  • Chemical Information
  • Solvent & Solubility
  • Purity & Documentation
  • References
  • Help & FAQs

All Bcr-Abl Isoforms

More
100 mg

Get Quote In-stock

Please select quantity
Amount: USD 0.00